We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK’s National Institute for Health and Care Excellence declined to recommend Bristol-Myers Squibb’s Opdivo for reimbursement in the treatment of advanced renal cell carcinoma. Read More
Horizon Therapeutics has filed suit against Par Pharmaceutical, alleging infringement of three patents for its urea cycle disorders drug Ravicti. Read More
Medical products companies spent $7.52 billion on physicians and teaching hospitals in 2015, roughly in line with 2014 results, according to the Centers for Medicare & Medicaid Services. Read More
The Association of the British Pharmaceutical Industry has suspended Astellas UK from the trade group, citing “serious breaches” of the group’s Code of Practice for the Pharmaceutical Industry. Read More